Llusern Scientific CEO and co-founder, Dr Emma Hayhurst, has been awarded the Innovation Prize from ‘Women in Innovation’.

With nearly 50% of women suffering from a UTI in their lifetimes and many thousands going on to develop chronic long-term symptoms, Emma and her colleagues at Llusern are working hard to improve diagnosis at point-of-care.

See more from BBC Wales:



The Lodestar DX analyser and testing system is registered with the European Patent Office (European Patent Application no: 22732302.9) and the US Patent and Trademark Office (no.18/558,490).